Loading...
Feasibility and Timing of Cytoreduction Surgery in Advanced (Metastatic or Recurrent) Gastrointestinal Stromal Tumors During the Era of Imatinib
The prognosis of advanced gastrointestinal stromal tumors (GISTs) was dramatically improved in the era of imatinib. Cytoreduction surgery was advocated as an additional treatment for advanced GISTs, especially when patients having poor response to imatinib or developing resistance to it. However, th...
Saved in:
| Published in: | Medicine (Baltimore) |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Wolters Kluwer Health
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4616552/ https://ncbi.nlm.nih.gov/pubmed/26091448 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000001014 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|